Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568837 · ClinicalTrials.gov registry record · Phase 4
Steroids After Spine Fusion Surgery
A Phase 4 study, sponsored by Oregon Health and Science University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 420
- Enrollment target
NCT04568837: Clinical Trial Phase 4 study, sponsored by Oregon Health and Science University.
NCT04568837 is a Phase 4 study that has not yet begun recruiting, run by Oregon Health and Science University. The registered enrollment target is 420 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04568837, a Phase 4 study, has not yet begun recruiting, sponsored by Oregon Health and Science University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 420 participants
- Enrollment target
Study Summary
This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.
Primary Outcome
This will be measured by converting the dosage of the pain medication administered to its equivalent dosage of morphine.
Interventions
- DRUG Prednisone 20 Mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2026-10-06 |
| Phase | Phase 4 |
What is known before NCT04568837 opens enrollment
NCT04568837 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 1 intervention - of which Prednisone 20 Mg is the first listed.
NCT04568837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04568837 about?
NCT04568837 is a clinical study titled "Steroids After Spine Fusion Surgery". This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.
What is the current status of trial NCT04568837?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 420 participants. The study started on 2025-03-01. Estimated completion is 2026-10-06.
What interventions are being tested in trial NCT04568837?
The interventions under investigation include: Prednisone 20 Mg (DRUG).
Who is sponsoring clinical trial NCT04568837?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04568837's enrollment target sits among peer trials
420 201st of 2000 higher than 1,799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI